RxDoctor Payments Data

Roberto Chuapoco, MD

Physical Medicine & Rehabilitation · Las Vegas, NVNPI 1891883922

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $550 and has fallen 68.1% since, to $175 in 2025.

$2,182in general payments, 2019–2025

Across 105 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • IBSA Pharma Inc.$352
  • Arbor Pharmaceuticals, Inc.$250
  • Novo Nordisk$236
  • GSK$183
  • Amgen$176
  • Gilead$125
  • plus $860 from 20 others

What the payments were for

  • Food & beverage$2,182100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,182 in reported general payments places this provider in the 85th percentile of 98 physical medicine & rehabilitation providers in Nevada.

See all physical medicine & rehabilitation providers in Nevada

Medicare billing

Part B allowed, 2024
$347,473
Medicare patients
1,044
Services billed
5,149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine37$6,073
Oxycodone Hcl330$5,468
Diclofenac Sodium31$5,263
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen338$5,102
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen170$3,795
Pregabalin136$3,447
Gabapentin293$3,303
Xtampza ErOxycodone Myristate12$1,782
Cyclobenzaprine Hcl161$1,510
Celecoxib101$1,413
Tramadol Hcl89$697
Baclofen47$648
Morphine Sulfate20$483
Acetaminophen-CodeineAcetaminophen With Codeine20$455
Pantoprazole Sodium21$392

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →